{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:07:59Z","timestamp":1791986879801,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ejropen.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology Open"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejro.2024.100598","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T21:25:10Z","timestamp":1725398710000},"page":"100598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma"],"prefix":"10.1016","volume":"13","author":[{"given":"Shuaishuai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejro.2024.100598_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.ejro.2024.100598_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-13-2159","article-title":"Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice","volume":"20","author":"Landgren","year":"2014","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejro.2024.100598_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/17474086.2018.1537776","article-title":"Prognostic factors for multiple myeloma in the era of novel therapies","volume":"11","author":"Ziogas","year":"2018","journal-title":"Expert Rev. Hematol."},{"issue":"3","key":"10.1016\/j.ejro.2024.100598_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.ejro.2024.100598_bib5","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.ejro.2024.100598_bib6","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ejro.2024.100598_bib7","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ejro.2024.100598_bib8","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ejro.2024.100598_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-021-00846-y","article-title":"The prognostic significance of [(18)F]FDG PET\/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)","volume":"11","author":"Sachpekidis","year":"2021","journal-title":"EJNMMI Res."},{"issue":"4","key":"10.1016\/j.ejro.2024.100598_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041030","article-title":"PET-FDG: impetus","volume":"12","author":"Nanni","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejro.2024.100598_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"5","key":"10.1016\/j.ejro.2024.100598_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00259-017-3909-8","article-title":"Interpretation criteria for FDG PET\/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)","volume":"45","author":"Nanni","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.ejro.2024.100598_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/JCO.20.00386","article-title":"Standardization of (18)F-FDG-PET\/CT according to deauville criteria for metabolic complete response definition in newly diagnosed multiple myeloma","volume":"39","author":"Zamagni","year":"2021","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejro.2024.100598_bib14","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1097\/RLU.0000000000000773","article-title":"(18)F-FDG dynamic PET\/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate","volume":"40","author":"Sachpekidis","year":"2015","journal-title":"Clin. Nucl. Med."},{"issue":"5","key":"10.1016\/j.ejro.2024.100598_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00259-020-05078-1","article-title":"A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy","volume":"48","author":"Paschali","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"10.1016\/j.ejro.2024.100598_bib16","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00277-021-04629-2","article-title":"Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value","volume":"100","author":"Li","year":"2021","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.ejro.2024.100598_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2214\/AJR.19.21283","article-title":"Medullary abnormalities in appendicular skeletons detected with (18)F-FDG PET\/CT predict an unfavorable prognosis in newly diagnosed multiple myeloma patients with high-risk factors","volume":"213","author":"Abe","year":"2019","journal-title":"AJR Am. J. Roentgenol."},{"issue":"6","key":"10.1016\/j.ejro.2024.100598_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","article-title":"Value of 18F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma","volume":"38","author":"Haznedar","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"9","key":"10.1016\/j.ejro.2024.100598_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13091570","article-title":"Multitracer PET\/CT with [18F]fluorodeoxiglucose and [18F]fluorocholine in the initial staging of multiple myeloma patients applying the IMPeTus criteria: a pilot study","volume":"13","author":"Garrastachu Zumar\u00e1n","year":"2023","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.ejro.2024.100598_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/RLU.0000000000004062","article-title":"New biomarkers with prognostic impact based on multitracer PET\/CT imaging in neuroendocrine neoplasms: the light leading out of the darkness in challenging tumors","volume":"47","author":"Delgado Bolton","year":"2022","journal-title":"Clin. Nucl. Med."}],"container-title":["European Journal of Radiology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352047724000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352047724000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T12:32:55Z","timestamp":1734179575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352047724000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"alternative-id":["S2352047724000534"],"URL":"https:\/\/doi.org\/10.1016\/j.ejro.2024.100598","relation":{},"ISSN":["2352-0477"],"issn-type":[{"value":"2352-0477","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejro.2024.100598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100598"}}